ConductScience.org, home

Paper38677331

Nelotanserin, a selective 5-HT2A receptor inverse agonist, attenuates aspects of nicotine withdrawal but not reward in mice.

Buzzi B and 3 others. Behav Brain Res, 2024. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Nelotanserin, a selective 5-HT2A receptor inverse agonist, attenuates aspects of nicotine withdrawal but not reward in mice. Papers, record 38677331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38677331

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Nelotanserin, a selective 5-HT2A receptor inverse agonist, attenuates aspects of nicotine withdrawal but not reward in mice.
PubMed
Journal
Behav Brain Res
PubMed
Year
2024
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
0
iCite
Relative citation ratio, by iCite
0.0, provisional
iCite
Revised in PubMed
2025-06-06
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Buzzi BBelle
2AlSharari SDShakir D
3Walentiny DMDavid M
4Damaj MIM Imad

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Substance Withdrawal SyndromeMajor topic
RewardMajor topic
NicotineMajor topic
Mice, Inbred ICRMajor topic
Serotonin 5-HT2 Receptor AgonistsMajor topic
Animals
Male
Mice
Dose-Response Relationship, Drug
Tobacco Use Disorder
Hyperalgesia
Receptor, Serotonin, 5-HT2A
Anxiety
Nicotinic Agonists

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
P30 DA033934NIDA NIH HHSUnited StatesP30DA033934PubMed and NIHNIH RePORTER
T32 DA007027NIDA NIH HHSUnited StatesT32DA007027PubMedNIH RePORTER

Download CSV of grants

References52

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
122342986Effects of the 5-HT2C receptor agonist Ro60-0175 and the 5-HT2A receptor antagonist M100907 on nicotine self-administration and reinstatement.Neuropharmacology2012https://conductscience.org/library/papers/22342986PubMed
237515363The 5-HT2A/2C inverse agonist nelotanserin alleviates L-DOPA-induced dyskinesia in the MPTP-lesioned marmoset.Eur J Neurosci2024https://conductscience.org/library/papers/37515363PubMed
332145488Suppression of cocaine relapse-like behaviors upon pimavanserin and lorcaserin co-administration.Neuropharmacology2020https://conductscience.org/library/papers/32145488PubMed
428095732An online survey of tobacco smoking cessation associated with naturalistic psychedelic use.J Psychopharmacol2017https://conductscience.org/library/papers/28095732PubMed
511441424Behavioral and neurochemical consequences of repeated nicotine treatment in the serotonin-depleted rat.Psychopharmacology (Berl)2001https://conductscience.org/library/papers/11441424PubMed
620153341Effects of serotonin (5-HT)2 receptor ligands on depression-like behavior during nicotine withdrawal.Neuropharmacology2010https://conductscience.org/library/papers/20153341PubMed
725739427Cartography of 5-HT1A and 5-HT2A Receptor Subtypes in Prefrontal Cortex and Its Projections.ACS Chem Neurosci2015https://conductscience.org/library/papers/25739427PubMed
832522572Central 5-HT receptors and their function; present and future.Neuropharmacology2020https://conductscience.org/library/papers/32522572PubMed
94148000Alteration of 5-hydroxytryptamine-14C efflux by nicotine in rat brain area slices.Neuropharmacology1973https://conductscience.org/library/papers/4148000PubMed
1020627663
The alpha2 adrenergic receptor antagonist idazoxan, but not the serotonin-2A receptor antagonist M100907, partially attenuated reward deficits associated with nicotine, but not amphetamine, withdrawal in rats.
Eur Neuropsychopharmacol2010https://conductscience.org/library/papers/20627663PubMed
1125505168Serotonin 5-HT2 receptor interactions with dopamine function: implications for therapeutics in cocaine use disorder.Pharmacol Rev2015https://conductscience.org/library/papers/25505168PubMed
1219090322APD125, a selective serotonin 5-HT(2A) receptor inverse agonist, significantly improves sleep maintenance in primary insomnia.Sleep2008https://conductscience.org/library/papers/19090322PubMed
1315565434Attenuation of nicotine's discriminative stimulus effects in rats and its locomotor activity effects in mice by serotonergic 5-HT2A/2C receptor agonists.Psychopharmacology (Berl)2005https://conductscience.org/library/papers/15565434PubMed
1424682754On the discovery and development of pimavanserin: a novel drug candidate for Parkinson's psychosis.Neurochem Res2014https://conductscience.org/library/papers/24682754PubMed
1518184829Differential role of nicotinic acetylcholine receptor subunits in physical and affective nicotine withdrawal signs.J Pharmacol Exp Ther2008https://conductscience.org/library/papers/18184829PubMed
1619841476Nelotanserin, a novel selective human 5-hydroxytryptamine2A inverse agonist for the treatment of insomnia.J Pharmacol Exp Ther2010https://conductscience.org/library/papers/19841476PubMed
1797182535-HT2A receptor subtype is involved in the thermal hyperalgesic mechanism of serotonin in the periphery.Pain1998https://conductscience.org/library/papers/9718253PubMed
181352387Effect of nicotine on extracellular levels of neurotransmitters assessed by microdialysis in various brain regions: role of glutamic acid.Neurochem Res1992https://conductscience.org/library/papers/1352387PubMed
19335416785-HT2A and 5-HT2C receptors as potential targets for the treatment of nicotine use and dependence.Prog Brain Res2021https://conductscience.org/library/papers/33541678PubMed
206805027Effects of chronic nicotine administration on the response and adaptation to stress.Psychopharmacology (Berl)1982https://conductscience.org/library/papers/6805027PubMed

See all 52 referencesDownload CSV of references

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
HTR2A3356PubTator's text mininghttps://conductscience.org/library/genes/3356

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Cited by
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/38677331

GET https://conductscience.org/api/papers/v1/38677331/references?page=2